What does the UK recession mean for FTSE 100 stocks?

Following news that the UK economy fell into recession at the end of 2023, Charlie Carman considers what could be next for FTSE 100 shares.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Hand flipping wooden cubes for change wording" Panic " to " Calm".

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

It’s official! Britain’s in recession. Following confirmation that UK GDP shrank in the last two quarters of 2023, many investors will be wondering what this means for FTSE 100 stocks.

The index’s initial reaction was fairly positive. On Thursday, the FTSE 100 closed nearly 0.4% higher as traders took the gloomy news in their stride. But what might the longer-term implications be?

Let’s explore.

Interest rates

One plausible reason the UK’s leading stocks showed resilience yesterday is the prospect of earlier interest rate cuts. Until now, policymakers have been firmly focused on bringing inflation down.

Falling interest rates tend to create a positive tailwind for shares as cash savings rates become less attractive and credit becomes cheaper.

Since the economy’s now in recession, speculation is growing that the Bank of England could reduce rates sooner than expected to spearhead some much-needed growth.

However, the central bank has an inflexible remit to maintain inflation at 2%. Currently, the rate’s still double that. Although earlier rate cuts may look like more likely today, if inflation remains stubborn, monetary policy could remain tight for a while yet.

Recession fallout

It’s important to note that the FTSE 100’s not as exposed to the UK economy as some investors may think. Around 80% of Footsie companies’ earnings are generated overseas.

This fact alone suggests many FTSE 100 shares may not suffer too much from a domestic recession. However, some firms in the index have a stronger UK focus than others.

For instance, many housebuilders, retailers, and some insurers derive the lion’s share of their revenues from domestic sources. Weak demand and sluggish growth prospects at home could be acutely felt in these sectors.

In addition, a recession may have wider-reaching consequences for all FTSE 100 shares. If GDP figures remain weak in 2024, this could have significant implications for fiscal policy and sterling’s performance in foreign exchange markets. These variables can have major consequences for all stocks in the index.

A FTSE 100 stock to consider

For investors who are particularly concerned about how to invest during a recession, defensive shares may be worth considering.

A good example is AstraZeneca (LSE:AZN), the Anglo-Swedish pharmaceutical giant.

Biotech and healthcare stocks are viewed as relatively recession-resistant investments because demand for their products remains fairly constant throughout all stages of the business cycle. AstraZeneca’s no exception.

The company has good revenue diversification across therapy areas and geographies, with relatively little reliance on the UK for its sales.

Market% of FY23 revenue
Emerging markets26%
Established RoW11%
Source: AstraZeneca

Despite a sharp fall in Covid-19 vaccine sales, the firm delivered a 6% revenue increase last year. Strong demand for its cancer medications bodes well for the future.

What’s more, AstraZeneca shares now trade at a forward price-to-earnings (P/E) ratio around 14.5. This multiple’s lower than it’s been for a while, which suggests today might potentially be a good opportunity to consider bagging cheap shares.

The company does face risks if its promising drugs pipeline fails to live up to expectations. Potential lawsuits or disappointing clinical trials can be major setbacks for pharma stocks.

Nonetheless, I think AstraZeneca is a solid FTSE 100 stock to consider while the UK’s in recession.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Charlie Carman has positions in AstraZeneca Plc. The Motley Fool UK has recommended AstraZeneca Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Up 75% in 5 years, I reckon this FTSE 250 still has lots to give!

Our writer explains why this FTSE 250 stock could still continue to provide growth and returns despite already being on…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

2 high-quality FTSE 250 stocks to consider buying

The FTSE 250 is home to some of the best investment opportunities out there. This Fool highlights two stocks for…

Read more »

Investing Articles

The Marks and Spencer share price dips! Is this my chance to buy?

Marks and Spencer was one of the hottest stocks on the market last year. With its share price falling in…

Read more »

Growth Shares

How low could the boohoo share price go?

Jon Smith explains why the enterprise value and the low risk of bankruptcy should help to prevent the boohoo share…

Read more »

Young Asian woman with head in hands at her desk
Investing Articles

Down 23% in a year! Can the Diageo share price regain £30 in 2024?

This Fool UK writer is checking the charts to see if the Diageo share price can recover from the recent…

Read more »

Asian man looking concerned while studying paperwork at his desk in an office
Investing Articles

I wouldn’t touch this FTSE 100 stalwart with a bargepole

Despite looking like a bargain on paper, this Fool is avoiding FTSE 100 constituent Vodafone at all costs. Here he…

Read more »

Investing Articles

I’m waiting for the Rolls-Royce share price to pull back before I buy

The Rolls-Royce share price has been the Footsie's best performer in the last year. But this Fool has no intention…

Read more »

Front view photo of a woman using digital tablet in London
Dividend Shares

2 dividend stocks to take me from £0 to £9.5k in second income

Jon Smith talks through some ideas with second income potential, including one stock that has a dividend yield above 10%…

Read more »